Picture of Integrated Diagnostics Holdings logo

IDHC Integrated Diagnostics Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

REG - Integrated Diag Hdgs - Result of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230530:nRSd0804Ba&default-theme=true

RNS Number : 0804B  Integrated Diagnostics Holdings PLC  30 May 2023

Integrated Diagnostics Holdings plc

(the "Company")

Result of Annual General Meeting

30 May 2023

 

 

The Company announces that at the Annual General Meeting of the Company held
today at the offices of Actis, 2 More London Riverside, London, SE1 2JT, all
resolutions contained in the notice of the meeting, including two special
resolutions were duly passed.  The special resolutions authorise the Company
to allot shares on a non-pre-emptive basis and to make market purchases of
Equity Securities in the capital of the Company.

 

Further information on the resolutions and the voting report will be available
on the Company's website at https://investors.idhcorp.com/

 

Copies of the resolutions passed as special resolutions at the AGM will
shortly be available for inspection at the National Storage Mechanism, which
is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 

ends-

 

 

For further information please contact:

 

 IDH
 Nancy Fahmy,                   +20 (0)12 2255 7445

 Investor Relations Director    nancy.fahmy@idhcorp.com

 Company Secretary

 Link Company Matters Limited   IDHLondon@linkgroup.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSDAFMSEDSELI

Recent news on Integrated Diagnostics Holdings

See all news